Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Personalized Dendritic Cell Vaccines-Recent Breakthroughs and Encouraging Clinical Results.

Mastelic-Gavillet B, Balint K, Boudousquie C, Gannon PO, Kandalaft LE.

Front Immunol. 2019 Apr 11;10:766. doi: 10.3389/fimmu.2019.00766. eCollection 2019. Review.

2.

Lymphatic vessel density is associated with CD8+ T cell infiltration and immunosuppressive factors in human melanoma.

Bordry N, Broggi MAS, de Jonge K, Schaeuble K, Gannon PO, Foukas PG, Danenberg E, Romano E, Baumgaertner P, Fankhauser M, Wald N, Cagnon L, Abed-Maillard S, Maby-El Hajjami H, Murray T, Ioannidou K, Letovanec I, Yan P, Michielin O, Matter M, Swartz MA, Speiser DE.

Oncoimmunology. 2018 May 31;7(8):e1462878. doi: 10.1080/2162402X.2018.1462878. eCollection 2018.

3.

Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity.

Bassani-Sternberg M, Chong C, Guillaume P, Solleder M, Pak H, Gannon PO, Kandalaft LE, Coukos G, Gfeller D.

PLoS Comput Biol. 2017 Aug 23;13(8):e1005725. doi: 10.1371/journal.pcbi.1005725. eCollection 2017 Aug.

4.

Heterogeneity assessment of functional T cell avidity.

Ioannidou K, Baumgaertner P, Gannon PO, Speiser MF, Allard M, Hebeisen M, Rufer N, Speiser DE.

Sci Rep. 2017 Mar 13;7:44320. doi: 10.1038/srep44320.

5.

Rapid and Continued T-Cell Differentiation into Long-term Effector and Memory Stem Cells in Vaccinated Melanoma Patients.

Gannon PO, Baumgaertner P, Huber A, Iancu EM, Cagnon L, Abed Maillard S, Maby-El Hajjami H, Speiser DE, Rufer N.

Clin Cancer Res. 2017 Jul 1;23(13):3285-3296. doi: 10.1158/1078-0432.CCR-16-1708. Epub 2016 Nov 21.

6.

Epitope located N-glycans impair the MHC-I epitope generation and presentation.

Chiritoiu GN, Jandus C, Munteanu CV, Ghenea S, Gannon PO, Romero P, Petrescu SM.

Electrophoresis. 2016 Jun;37(11):1448-60. doi: 10.1002/elps.201500449. Epub 2016 Feb 3.

PMID:
26701645
7.

Identifying Individual T Cell Receptors of Optimal Avidity for Tumor Antigens.

Hebeisen M, Allard M, Gannon PO, Schmidt J, Speiser DE, Rufer N.

Front Immunol. 2015 Nov 18;6:582. doi: 10.3389/fimmu.2015.00582. eCollection 2015. Review.

8.

Potential Cross-Talk between Alternative and Classical NF-κB Pathways in Prostate Cancer Tissues as Measured by a Multi-Staining Immunofluorescence Co-Localization Assay.

Labouba I, Le Page C, Communal L, Kristessen T, You X, Péant B, Barrès V, Gannon PO, Mes-Masson AM, Saad F.

PLoS One. 2015 Jul 17;10(7):e0131024. doi: 10.1371/journal.pone.0131024. eCollection 2015.

9.

Quantitative TCR:pMHC Dissociation Rate Assessment by NTAmers Reveals Antimelanoma T Cell Repertoires Enriched for High Functional Competence.

Gannon PO, Wieckowski S, Baumgaertner P, Hebeisen M, Allard M, Speiser DE, Rufer N.

J Immunol. 2015 Jul 1;195(1):356-66. doi: 10.4049/jimmunol.1403145. Epub 2015 May 22.

10.

Long-lasting stem cell-like memory CD8+ T cells with a naïve-like profile upon yellow fever vaccination.

Fuertes Marraco SA, Soneson C, Cagnon L, Gannon PO, Allard M, Abed Maillard S, Montandon N, Rufer N, Waldvogel S, Delorenzi M, Speiser DE.

Sci Transl Med. 2015 Apr 8;7(282):282ra48. doi: 10.1126/scitranslmed.aaa3700.

11.

Pulmonary sarcoid-like granulomatosis after multiple vaccinations of a long-term surviving patient with metastatic melanoma.

Bordry N, Costa-Nunes CM, Cagnon L, Gannon PO, Abed-Maillard S, Baumgaertner P, Murray T, Letovanec I, Lazor R, Bouchaab H, Rufer N, Romano E, Michielin O, Speiser DE.

Cancer Immunol Res. 2014 Dec;2(12):1148-53. doi: 10.1158/2326-6066.CIR-14-0143. Epub 2014 Oct 2.

12.

The RelB alternative NF-kappaB subunit promotes autophagy in 22Rv1 prostate cancer cells in vitro and affects mouse xenograft tumor growth in vivo.

Labouba I, Poisson A, Lafontaine J, Delvoye N, Gannon PO, Le Page C, Saad F, Mes-Masson AM.

Cancer Cell Int. 2014 Jul 28;14:67. doi: 10.1186/1475-2867-14-67. eCollection 2014.

13.

Persistence of EBV antigen-specific CD8 T cell clonotypes during homeostatic immune reconstitution in cancer patients.

Iancu EM, Gannon PO, Laurent J, Gupta B, Romero P, Michielin O, Romano E, Speiser DE, Rufer N.

PLoS One. 2013 Oct 25;8(10):e78686. doi: 10.1371/journal.pone.0078686. eCollection 2013.

14.

Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer.

Gannon PO, Lessard L, Stevens LM, Forest V, Bégin LR, Minner S, Tennstedt P, Schlomm T, Mes-Masson AM, Saad F.

Eur J Cancer. 2013 Jul;49(10):2441-8. doi: 10.1016/j.ejca.2013.02.026. Epub 2013 Mar 28.

PMID:
23541563
15.

Simultaneous coexpression of memory-related and effector-related genes by individual human CD8 T cells depends on antigen specificity and differentiation.

Gupta B, Iancu EM, Gannon PO, Wieckowski S, Baitsch L, Speiser DE, Rufer N.

J Immunother. 2012 Jul;35(6):488-501. doi: 10.1097/CJI.0b013e31826183a7.

16.

p53 inhibits angiogenesis by inducing the production of Arresten.

Assadian S, El-Assaad W, Wang XQ, Gannon PO, Barrès V, Latour M, Mes-Masson AM, Saad F, Sado Y, Dostie J, Teodoro JG.

Cancer Res. 2012 Mar 1;72(5):1270-9. doi: 10.1158/0008-5472.CAN-11-2348. Epub 2012 Jan 17.

17.

Updates on therapeutic targets and agents in castration-resistant prostate cancer.

Bishr M, Lattouf JB, Gannon PO, Saad F.

Minerva Urol Nefrol. 2011 Jun;63(2):131-43. Review.

PMID:
21623331
18.

Influence of pH on the Cytotoxic Activity of Inositol Hexakisphosphate (IP6) in Prostate Cancer.

Betton B, Gannon PO, Koumakpayi IH, Diallo JS, Mes-Masson AM, Saad F.

Front Oncol. 2011 Oct 31;1:40. doi: 10.3389/fonc.2011.00040. eCollection 2011.

19.

Androgen-regulated expression of arginase 1, arginase 2 and interleukin-8 in human prostate cancer.

Gannon PO, Godin-Ethier J, Hassler M, Delvoye N, Aversa M, Poisson AO, Péant B, Alam Fahmy M, Saad F, Lapointe R, Mes-Masson AM.

PLoS One. 2010 Aug 11;5(8):e12107. doi: 10.1371/journal.pone.0012107.

20.

Impact of hemochromatosis gene (HFE) mutations on epithelial ovarian cancer risk and prognosis.

Gannon PO, Medelci S, Le Page C, Beaulieu M, Provencher DM, Mes-Masson AM, Santos MM.

Int J Cancer. 2011 May 15;128(10):2326-34. doi: 10.1002/ijc.25577.

21.

Phenotypic characterization of chronic inflammation in a rare case of endobronchial carcinoma.

Gannon PO, Turcotte S, Laporte JL, Saad F, Lapointe R, Duranceau A.

Cancer Immunol Immunother. 2010 Sep;59(9):1411-6. doi: 10.1007/s00262-010-0861-x. Epub 2010 May 20.

PMID:
20490490
22.

Human activated T lymphocytes modulate IDO expression in tumors through Th1/Th2 balance.

Godin-Ethier J, Pelletier S, Hanafi LA, Gannon PO, Forget MA, Routy JP, Boulassel MR, Krzemien U, Tanguay S, Lattouf JB, Arbour N, Lapointe R.

J Immunol. 2009 Dec 15;183(12):7752-60. doi: 10.4049/jimmunol.0901004.

23.

Characterization of the intra-prostatic immune cell infiltration in androgen-deprived prostate cancer patients.

Gannon PO, Poisson AO, Delvoye N, Lapointe R, Mes-Masson AM, Saad F.

J Immunol Methods. 2009 Aug 31;348(1-2):9-17. doi: 10.1016/j.jim.2009.06.004. Epub 2009 Jun 22.

PMID:
19552894
24.

Ebp1 expression in benign and malignant prostate.

Gannon PO, Koumakpayi IH, Le Page C, Karakiewicz PI, Mes-Masson AM, Saad F.

Cancer Cell Int. 2008 Nov 24;8:18. doi: 10.1186/1475-2867-8-18.

25.

Presence of prostate cancer metastasis correlates with lower lymph node reactivity.

Gannon PO, Alam Fahmy M, Bégin LR, Djoukhadjian A, Filali-Mouhim A, Lapointe R, Mes-Masson AM, Saad F.

Prostate. 2006 Dec 1;66(16):1710-20.

PMID:
16955408
26.

Fibrosis, matrix metalloproteinases, and inflammation in the heart of DOCA-salt hypertensive rats: role of ET(A) receptors.

Ammarguellat FZ, Gannon PO, Amiri F, Schiffrin EL.

Hypertension. 2002 Feb;39(2 Pt 2):679-84.

PMID:
11882630

Supplemental Content

Loading ...
Support Center